← Back to Search

Treatment for Colon Cancer

N/A
Recruiting
Led By Aadel Chaudhuri, M.D., Ph.D.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Eligible healthy donors will be at least 18 years of age.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through completion of study (estimated to be 6.5 years)
Awards & highlights
No Placebo-Only Group

Summary

This trial has the potential to improve patient outcomes by detecting disease recurrence earlier and offering greater treatment options.

Eligible Conditions
  • Breast Cancer
  • Head and Neck Cancers
  • Colon Cancer
  • Gastrointestinal Cancer
  • Healthy Subjects
  • Skin Cancer
  • Sarcoma
  • Lung Cancer
  • Melanoma
  • Genitourinary Cancers
  • Cancer
  • Prostate Cancer
  • Esophageal Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through completion of study (estimated to be 6.5 years)
This trial's timeline: 3 weeks for screening, Varies for treatment, and through completion of study (estimated to be 6.5 years) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Freedom from progression
Secondary study objectives
Disease-specific survival
Distant-metastasis-free survival
Event-free survival
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Find a Location

Who is running the clinical trial?

National Center for Advancing Translational Science (NCATS)NIH
99 Previous Clinical Trials
32,024 Total Patients Enrolled
Roche Sequencing SolutionsIndustry Sponsor
2 Previous Clinical Trials
22,955 Total Patients Enrolled
The V Foundation for Cancer ResearchOTHER
20 Previous Clinical Trials
1,208 Total Patients Enrolled
~15 spots leftby Dec 2025